D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
RAPT RAPT Therapeutics
- 1.070
- -0.060-5.31%
Close Mar 10 16:00 ET
- 1.080
- +0.010+0.93%
Post 17:15 ET
141.25MMarket Cap-0.34P/E (TTM)
1.170High1.060Low713.76KVolume1.130Open1.130Pre Close776.40KTurnover1.22%Turnover RatioLossP/E (Static)132.01MShares9.65452wk High0.74P/B62.54MFloat Cap0.78952wk Low--Dividend TTM58.45MShs Float51.210Historical High--Div YieldTTM9.74%Amplitude0.789Historical Low1.087Avg Price1Lot Size
About RAPT Therapeutics Company
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Company Profile
SymbolRAPT
Company NameRAPT Therapeutics
Listing DateOct 31, 2019
Issue Price12.00
Founded2015
CEODr. Brian Russell Wong, M.D.,PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address561 Eccles Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-489-9000
Websitehttp://rapt.com
Company Executives
- Name
- Position
- Salary
- Dr. Brian Russell Wong, M.D.,PhD
- President, Chief Executive Officer and Director
- 6.59M
- Dr. William Ho, M.D.,PhD
- Chief Medical Officer
- 1.90M
- Rodney Young
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 2.18M
- Dr. Dirk G. Brockstedt, PhD
- Chief Scientific Officer
- --
- Lori Lyons-Williams
- Chairman of the Board
- 262.28K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 277.78K
- Linda Kozick
- Independent Director
- 260.78K
- Dr. Wendye Robbins, M.D.
- Independent Director
- 265.28K
- Dr. Michael F. Giordano, M.D.
- Independent Director
- 267.78K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.